KA
Kairos Pharma, Ltd. (KAPA)
AMEX·Healthcare·Biotechnology
$0.49
+0.23%
Mkt Cap $1.84M
No analyst coverage available
We don't have analyst ratings or price target data for Kairos Pharma, Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.